Abstract:Objective: To evaluate the relationship between insulin resistance and endothelial function in type 2 diabetes patients with or without microalbuminuria and to explore the pathophysiological mechanisms of the increased macrovascular risk in type 2 diabetes mellitus. Methods: Twelve type 2 diabetes patients with microalbuminuria (urinary albumin 30–300 μg/mg creatinine, DM-MA) and 12 type 2 diabetes patients without microalbuminuria (urinary albumin <30 μg/mg creatinine, DM-NA) were recruited, matched for their sex, age, body mass index (BMI), diabetes duration, antidiabetic therapy. Their hemoglobin (HbA1C) was less than 7.5% and the blood pressure was lower than 140/90 mmHg. None had evidence of macrovascular disease and serum cholesterol levels were normal. Twelve healthy volunteers (C) were enrolled as controls. All subjects received a hyperinsulinemic euglycemic clamp study (insulin infusion rate, 120 mU/m2/min) to assess the peripheral glucose disposal rate (GDR) in the steady state and had a high-resolution ultrasonography to measure vasodilation in the brachial artery diameter in response to reactive hyperemia (endothelium-dependent) and administration of glyceryl trinitrate (endothelium-independent). Plasma free fatty acids (FFAs), plasminogen activator inhibitor type I (PAI-1), and von Willebrand factor (vWF) were also measured. Results: The GDR was lower in type 2 diabetes patients with microalbuminuria (7.90±1.79 mg/kg/min) than in patients without microalbuminuria (9.46±1.59 mg/kg/min, P<0.05), and the GDR in both diabetes groups was decreased, compared with the findings from the healthy control group (13.06±1.98 mg/kg/min, P<0.01). Plasma FFAs concentration was different among the three groups (DM-MA—1008±229 μmol/l, DM-NA—675±201 μmol/l, P<0.01; C—364±169 μmol/l, P<0.01). Endothelium-dependent vasodilation was impaired in the microalbuminuric patients (8.0±3.8%) compared with the normoalbuminuria patients (9.7±4.3%, P>0.05) and the healthy controls (14.2±5.0, P<0.05). Plasma PAI-1 and vWF levels increased in the microalbuminuric patients (61.9±18.2 ng/ml, 126.8 (76.5–212.7) %) compared with the levels in the normoalbuminuric patients (45.4±16.3 ng/ml, 87.9 (84.2–114) %) (PAI-1, P<0.05; vWF, P>0.05) and in the healthy controls (33.6±10.6 ng/ml, 67.2 (61.5–75.4) %, both P<0.01). In addition, the partial correlation analysis revealed a significant positive correlation between GDR and endothelium-dependent vasodilation (r=0.465, P<0.01, n=36), and a negative correlation between GDR and plasma FFA levels (P<0.05). Conclusions: Compared with type 2 diabetes patients with normoalbuminuria, patients with microalbuminuria had more severe insulin resistance, more prominent endothelial dysfunction, and higher plasma FFA, PAI-1, and vWF levels. Therefore we speculate that insulin resistance and endothelial dysfunction may act within the metabolic syndrome to increase the cardiovasular risk in this subset of patients, and improving insulin resistance and endothelial dysfunction may reduce the morbidity and mortality from macrovascular complications in type 2 diabetes patients.

[Study on the Associations Between Inflammatory Factor and Insulin Resistance As Well As Type 2 Diabetes with Macrovascular Complications].

Role of Inflammatory Markers C-reactive Protein, High Sensitivity C-reactive Protein in Diabetes and Its Cardiovascular Complications

C-reactive Protein for Predicting Cardiovascular and All-Cause Mortality in Type 2 Diabetic Patients: A Meta-Analysis

The Study of High Sensitivity C-reactive Protein and Blood Lipid Application in Macrovascular Disease in Diabetics

Associations between inflammatory markers, traditional risk factors, and complications in patients with type 2 diabetes mellitus

Analysis of the correlation of sEPCR, hs-CRP, TNF-α and IL-18 levels with macroangiopathy in type 2 diabetes mellitus patients

Temporal relationship between inflammation and insulin resistance and their joint effect on hyperglycemia: the Bogalusa Heart Study

Relationship Between Plasma Concentrations of Resistin and Type 2 Diabetes Mellitus with Macroangiopathies

Impact of Diabetic Macroangiopathy on Correlation Between High Sensitivity C-reactive Protein and Low Density Lipoprotein Cholesterol in Urban Fringe Zone in Chengdu

The Relationship of Serum Uric Acid Concentration with Insulin Resistance and Macrovascular Complications in Type 2 Diabetes Mellitus

Relationship Between Serum High Sensitivity C-Reative Protein and Atherosclerosis in Patients with Diabetes Mellitus

Observation on the relationship between serum macrophage inhibitory cytokine-1 and carotid plaque in type 2 diabetic patients

The Correlation of Adiponectin, IL-6 with Insulin Resistance and Macrovascular Lesion in Type 2 Diabetes

Relationship of Carotid Intima-media Thickness with Serum High Sensitive C-reactive Protein and Insulin Resistance Risk Factors in Type 2 Diabetes Mellitus

High Sensitivity C-reactive Protein is Associated with Carotid Intimal Medial Thickness in Type 2 Diabetes Mellitus

Analysis of Correlated Factors Influencing Macroangiopathy in Patients with New Onset Type 2 Diabetes Mellitus

Insulin resistance is independently associated with cardiovascular autonomic neuropathy in type 2 diabetes

Insulin Resistance and Endothelial Dysfunction in Type 2 Diabetes Patients with or Without Microalbuminuria.

Relationship between serum hypoxia-inducible factor-1α and carotid plaque in patients with type 2 diabetes mellitus

Analysis of the Correlation Between Plasma Coagulation Factor VII, PAI-1, and Uric Acid with Insulin Resistance and Macrovascular Complications in Elderly Patients with Type 2 Diabetes

Study on Macrovascular Lesion Related Clinical Factors in Type 2 Diabetes Mellitus Patients